Mainz Biomed NV (MYNZ) is up Monday morning, with the stock climbing 8.25% in pre-market trading to 1.05. MYNZ's short-term technical score of 6 indicates that the stock has traded less bullishly over the last month than 94% of stocks on the market. In the Diagnostics & Research industry, which ranks 104 out of 146 industries, MYNZ ranks higher than 7% of stocks. Mainz Biomed NV has fallen 9.35% over the past month, closing at $1.02 on February 12. During this period of time, the stock fell as low as $0.88 and as high as $1.07. MYNZ has an average analyst recommendation of Buy. The company has an average price target of $3.00.
MYNZ has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on MYNZ!